You have 9 free searches left this month | for more free features.

Condition

Acute Leukemia (1)

Acute Lymphoblastic Leukemia (ALL) (1)

Overall Status

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Guangdong Provincial People's Hospital (1)

Spectrum Pharmaceuticals, Inc (1)

Collaborator

Chinese Academy of Sciences (1)

Guangdong Zhaotai InVivo Biomedicine Co. Ltd. (1)

Parexel (1)

Intervention

cd19-car-t2 cells (1)

marqibo® (vincristine sulfate liposomes injection) (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

leukimia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))

Completed

Has Results

Acute Lymphoblastic Leukemia (ALL)

Marqibo® (vincristine sulfate liposomes injection)

Los Angeles, California
+32 more

Feb 8, 2021

Acute Leukemia Trial in Guangzhou (CD19-CAR-T2 Cells)

Unknown status

Acute Leukemia

CD19-CAR-T2 Cells

Guangzhou, Guangdong, China

Guangdong General Hospital

Sep 8, 2017